GE HealthCare Technologies (NASDAQ:GEHC) Price Target Lowered to $80.00 at BTIG Research

GE HealthCare Technologies (NASDAQ:GEHC) had its price target trimmed by BTIG Research from $85.00 to $80.00 in a report released on Wednesday morning,Benzinga reports. The brokerage currently has a buy rating on the stock.

A number of other research analysts also recently commented on GEHC. Evercore upped their price objective on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the company an “outperform” rating in a research note on Thursday, February 5th. Piper Sandler dropped their price objective on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Barclays increased their target price on shares of GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an “equal weight” rating in a research report on Friday, February 6th. Morgan Stanley increased their target price on shares of GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an “equal weight” rating in a research report on Wednesday, February 4th. Finally, UBS Group downgraded shares of GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. Seven analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $88.00.

GE HealthCare Technologies Trading Down 13.2%

NASDAQ GEHC opened at $59.49 on Wednesday. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a 50-day moving average of $73.72 and a 200-day moving average of $77.64. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 1.13. The company has a market cap of $27.14 billion, a P/E ratio of 13.05, a P/E/G ratio of 1.55 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Wednesday, April 29th. The company reported $0.99 EPS for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. The company had revenue of $5.13 billion for the quarter, compared to analyst estimates of $5.03 billion. During the same period in the prior year, the company earned $1.01 EPS. The company’s revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. As a group, equities analysts predict that GE HealthCare Technologies will post 5 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date of this dividend is Thursday, April 2nd. GE HealthCare Technologies’s dividend payout ratio is 3.07%.

Institutional Trading of GE HealthCare Technologies

A number of institutional investors and hedge funds have recently bought and sold shares of GEHC. Temasek Holdings Private Ltd purchased a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $99,922,000. Locust Wood Capital Advisers LLC boosted its holdings in GE HealthCare Technologies by 7.1% in the 3rd quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company’s stock worth $156,534,000 after acquiring an additional 137,992 shares during the period. Nan Fung Trinity HK Ltd. purchased a new position in GE HealthCare Technologies in the 3rd quarter worth approximately $23,206,000. Envestnet Asset Management Inc. boosted its holdings in GE HealthCare Technologies by 15.8% in the 3rd quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company’s stock worth $25,452,000 after acquiring an additional 46,231 shares during the period. Finally, Sound Shore Management Inc CT boosted its holdings in GE HealthCare Technologies by 14.6% in the 3rd quarter. Sound Shore Management Inc CT now owns 980,756 shares of the company’s stock worth $73,655,000 after acquiring an additional 125,062 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

GE HealthCare Technologies News Summary

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Top-line beat — Q1 revenue of $5.13B topped Street estimates (~$5.03B) and revenue was up ~7.4% year/year, showing underlying demand in Imaging, AVS and Pharma Diagnostics. Press Release / Slide Deck
• Positive Sentiment: Analyst support remains — BTIG trimmed its price target from $85 to $80 but kept a “buy” rating, signaling continued analyst conviction in longer‑term upside despite near‑term headwinds. Benzinga
• Neutral Sentiment: Operational reorganization — Management combined Imaging and Advanced Visualization Solutions into a new Advanced Imaging Solutions ($14.6B) segment and named Phil Rackliffe president/CEO of AIS to improve execution and efficiencies; this is intended to drive scale but will take time to show results. Business Wire — Exec & Operational Updates
• Neutral Sentiment: Earnings call/transcript available — Management emphasized strong topline execution but acknowledged margin pressure and cost headwinds; the conference call provides more detail for investors who want to hear management’s mitigation plans. SA Earnings Call Transcript
• Negative Sentiment: EPS miss — Reported EPS $0.99 vs. consensus ~$1.07, missing estimates and coming in slightly below last year’s $1.01, a key trigger for the selloff. Zacks — EPS Miss
• Negative Sentiment: Guidance cut — FY26 EPS guidance was lowered to $4.80–$5.00 vs. consensus ~5.05, signaling margin pressure ahead and reducing near‑term earnings visibility. Press Release — Guidance
• Negative Sentiment: Inflation & supply‑chain costs — Management blamed higher memory chip, oil and freight costs, tariffs and other supply pressures for margin deterioration; Reuters/WSJ reports highlight these cost drivers as the main rationale for the outlook cut. Reuters — Inflation Weighs on Costs
• Negative Sentiment: Market reaction — Investors sold shares on the combination of the EPS miss, guidance cut and margin concerns, producing heavy volume and a sharp intraday decline. Proactive Investors — Shares Tumble

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.